ARTICLE | Company News
Glaxo seeks Relenza approval for flu prevention
September 18, 2000 7:00 AM UTC
GLX filed for FDA marketing approval of Relenza zanamivir for the prevention of influenza A and B. The product, which received priority review, was approved to treat influenza last year (see BioCentu...